In unscreened adults who refuse colonoscopy, liquid biopsy tests may not have sufficient performance and cost too much to be a viable strategy at this time, an economic analysis suggests.
Grail announced a step that may help move the company closer to securing Medicare reimbursement for its Galleri multicancer blood test, sold in the US since 2021.
Marcy Duncan hadn t fully healed from her surgery for stage I breast cancer. She expected to discuss radiation and other next treatment steps. But her doctor raised a more serious concern.
Measuring ctDNA levels before radiotherapy predicted PFS and overall survival, and can help determine the patients most likely to benefit from consolidation radiotherapy vs systemic therapy.